| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23.3M | — | +1633.9% |
| R&D Expense | $5.6M | — | -46.2% |
| SG&A Expense | $21.0M | — | +70.3% |
| Operating Income | -$6.0M | — | +73.5% |
| Pre-tax Income | -$7.9M | — | +85.4% |
| Income Tax | $0 | — | — |
| Net Income | -$7.9M | — | +85.4% |
| EPS (Basic) | -$0.02 | — | +88.9% |
| EPS (Diluted) | -$0.02 | — | +88.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.5M | -75.3% | +23.5% |
| Short-term Investments | $48.8M | -27.9% | -34.3% |
| Accounts Receivable | $26.4M | +574.2% | +3415.7% |
| Inventory | $14.7M | +53.7% | — |
| Current Assets | $101.7M | -11.8% | +20.2% |
| Total Assets | $138.6M | -10.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$43.8M | — | -168.5% |
| Capital Expenditures | $258K | — | -58.5% |
| Investing Cash Flow | $21.0M | — | +424.7% |
| Financing Cash Flow | $109K | — | +116.1% |
| Free Cash Flow | -$44.1M | — | -160.1% |
| +7.6% |
| Current Liabilities | $21.1M | -43.4% | -12.0% |
| Long-term Debt | $93.5M | +0.4% | — |
| Total Liabilities | $118.4M | -12.0% | +4.5% |
| Stockholders' Equity | $20.2M | -3.2% | +243.9% |